Scrip
EMA's restructured fee model may increase overall burden on drug firms
06 July 2010
Vibha Sharma
Please Login to read the full article.
06 July 2010
Vibha Sharma
The
European Medicines Agency is planning to restructure its current fee model so that there is "greater balance" between the money paid by pharmaceutical companies and the level of services provided by the agency. The proposed model, if approved, would effectively do away with the "tailor-made"...
Please Login to read the full article.
RELATED CONTENT
FEATURES
- European generics industry throws its weight behind IMPACT
- Anti-obesity drugs: an inventor's perspective
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
